Overview

Exoskeleton Market is poised to value USD 5131 million by 2028 end at a CAGR of 38.1% during the forecast period 2022 to 2028.

FutureWise Market Research has instantiated a report that provides a comprehensive analysis of Exoskeleton Market trends that influence the overall market growth. Furthermore, it includes elaborative insights on the graph of profitability, SWOT analysis, market share and regional business growth. Moreover, the report offers apprehension on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Exoskeleton Market is predicted to achieve substantial growth by the end of the forecast period. The report explains that this business is anticipated to record a noteworthy growth rate over the forecasted timeframe. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also includes a thorough list of market segmentations along with the growth opportunities across this business vertical.

Major players included in the Exoskeleton Market:
• ReWalk Robotics Ltd.
• Ekso Bionics
• Rex Bionics Plc
• Suit X (U.S. Bionics Inc.)
• Lockheed Martin Corporation
• Hocoma
• Parker Hannifin Corporation
• Hyundai Motor Company
• Axiobionics
• Myomo, Inc.
• Honda Motor Co. Ltd.
• Technaid. S.L.
• Gogoa Mobility Robots SL
• Wearable Robotics SRL
• DIH Technologies Corporation
(Note: The list of the major players will be updated with the latest market scenario and trends)

Exoskeleton Market Segmentation:
By Component
• Hardware
  o Sensor
  o Actuator
  o Power Source
  o Control System/Controller
  o Others (Body Material and other Electronic, Electrical, and Mechanical Components)
• Software

By Type
• Powered
• Passive

By Mobility
• Stationary
• Mobile

By Body Part
• Lower Extremities
• Upper Extremities
• Full Body

By Vertical
• Healthcare
• Defense
• Industrial
• Others (Construction, Search and Rescue, Space, Agriculture, Education, and Sports and Fitness)

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Exoskeleton Market By Component,By Type,By Mobility,By Body Part,By Vertical and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- Type launches, technological advancements, mergers and expansions

Flexible Model:
• We have a flexible Model and you can suggest changes in the scope/table of content as per your requirement
• The customisations offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Exoskeleton Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Exoskeleton Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Exoskeleton Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Exoskeleton Market, By Component Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Hardware
        7.1.1. Sensor
        7.1.2. Actuator
        7.1.3. Power Source
        7.1.4. Control System/Controller
        7.1.5. Others (Body Material and other Electronic, Electrical, and Mechanical Components)
   7.2. Software

8. Exoskeleton Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)  
   8.1. Powered
   8.2. Passive

9. Exoskeleton Market, By Mobility Historical Analysis and Forecast 2022-2028 (USD Million)  
   9.1. Stationary
   9.2. Mobile

10. Exoskeleton Market, By Body Part Historical Analysis and Forecast 2022-2028 (USD Million)  
    10.1. Lower Extremities
    10.2. Upper Extremities
    10.3. Full Body

11. Exoskeleton Market, By Vertical Historical Analysis and Forecast 2022-2028 (USD Million)  
    11.1. Healthcare
    11.2. Defense
    11.3. Industrial
    11.4. Others (Construction, Search and Rescue, Space, Agriculture, Education, and Sports and Fitness)

12. North America Exoskeleton Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. U.S.A
          12.2.2. Canada
          12.2.3. Mexico
    12.3. Market Size (USD Million) Forecast for North America 2022-2028

13. Latin America Exoskeleton Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. Brazil
          13.2.2. Venezuela
          13.2.3. Argentina
          13.2.4. Rest of Latin America
    13.3. Market Size (USD Million) Forecast for Latin America 2022-2028

14. Europe Exoskeleton Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. Germany
          14.2.2. U.K         
          14.2.3. France
          14.2.4. Italy
          14.2.5. Spain
          14.2.6. Russia
          14.2.7. Poland
          14.2.8. Rest of Europe
    14.3. Market Size (USD Million) Forecast for Europe 2022-2028

15. Asia Pacific Exoskeleton Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    15.1. Introduction
    15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          15.2.1. Japan
          15.2.2. China
          15.2.3. India
          15.2.4. Australia and New Zealand
          15.2.5. ASEAN
          15.2.6. Rest of Asia Pacific
    15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    16.1. Introduction
    16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          16.2.1. GCC
          16.2.2. Israel
          16.2.3. South Africa
          16.2.4. Rest of MEA
    16.3. Market Size (USD Million) Forecast for MEA 2022-2028

17. Market Share Analysis and Competitive Landscape   
    17.1. Global Landscape - Key Players, Revenue and Presence
    17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    17.3. Global Emerging Companies
    17.4. North America - Market Share Analysis and Key Regional Players
    17.5. Europe - Market Share Analysis and Key Regional Players
    17.6. Asia Pacific - Market Share Analysis and Key Regional Players
    17.7. Global Key Player - Growth Matrix

18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   18.1. ReWalk Robotics Ltd.
         18.1.1. Company Overview
         18.1.2. Type Portfolio
         18.1.3. SWOT Analysis
         18.1.4. Financial Overview
         18.1.5. Strategic Overview
   18.2. Ekso Bionics
         18.2.1. Company Overview
         18.2.2. Type Portfolio
         18.2.3. SWOT Analysis
         18.2.4. Financial Overview
         18.2.5. Strategic Overview
   18.3. Rex Bionics Plc
         18.3.1. Company Overview
         18.3.2. Type Portfolio
         18.3.3. SWOT Analysis
         18.3.4. Financial Overview
         18.3.5. Strategic Overview
   18.4. Suit X (U.S. Bionics Inc.)
         18.4.2. Type Portfolio
         18.4.3. SWOT Analysis
         18.4.4. Financial Overview
         18.4.5. Strategic Overview
   18.5. Lockheed Martin Corporation
         18.5.1. Company Overview
         18.5.2. Type Portfolio
         18.5.3. SWOT Analysis
         18.5.4. Financial Overview
         18.5.5. Strategic Overview          
   18.6. Hocoma
         18.6.1. Company Overview
         18.6.2. Type Portfolio
         18.6.3. SWOT Analysis
         18.6.4. Financial Overview
         18.6.5. Strategic Overview      
   18.7. Parker Hannifin Corporation
         18.7.1. Company Overview
         18.7.2. Type Portfolio
         18.7.3. SWOT Analysis
         18.7.4. Financial Overview
         18.7.5. Strategic Overview
   18.8. Hyundai Motor Company
         18.8.1. Company Overview
         18.8.2. Type Portfolio
         18.8.3. SWOT Analysis
         18.8.4. Financial Overview
         18.8.5. Strategic Overview
   18.9. Axiobionics
         18.9.1. Company Overview
         18.9.2. Type Portfolio
         18.9.3. SWOT Analysis
         18.9.4. Financial Overview
         18.9.5. Strategic Overview
   18.10.Myomo, Inc.  
         18.10.1. Company Overview
         18.10.2. Type Portfolio
         18.10.3. SWOT Analysis
         18.10.4. Financial Overview
         18.10.5. Strategic Overview
   18.11.Honda Motor Co. Ltd.
         18.11.1. Company Overview
         18.11.2. Type Portfolio
         18.11.3. SWOT Analysis
         18.11.4. Financial Overview
         18.11.5. Strategic Overview
   18.12.Technaid. S.L.
         18.12.1. Company Overview
         18.12.2. Type Portfolio
         18.12.3. SWOT Analysis
         18.12.4. Financial Overview
         18.12.5. Strategic Overview
   18.13.Gogoa Mobility Robots SL
         18.13.1. Company Overview
         18.13.2. Type Portfolio
         18.13.3. SWOT Analysis
         18.13.4. Financial Overview
         18.13.5. Strategic Overview
   18.14.Wearable Robotics SRL
         18.14.1. Company Overview
         18.14.2. Type Portfolio
         18.14.3. SWOT Analysis
         18.14.4. Financial Overview
         18.14.5. Strategic Overview
   18.15.DIH Technologies Corporation
         18.15.1. Company Overview
         18.15.2. Type Portfolio
         18.15.3. SWOT Analysis
         18.15.4. Financial Overview
         18.15.5. Strategic Overview

19. Pre and Post COVID-19 Impact
    19.1. Positive influence on the healthcare industry
    19.2. The financial disruption of the manufacturing sector
    19.3. Impact of COVID-19 on emerging companies
    19.4. Significant mandates in the healthcare regulations initiated by administrations
    19.5. The overall economic slowdown of the developing and developed nations

20. FutureWise SME Key Takeaway Points for Client

Tables

Figures